Comparing how new cardiovascular treatments are adopted or not adopted in rich countries
Official title: Comparing approval, adoption/de-adoption and outcomes for advanced cardiovascular procedures across high-income countries
Funded at Harvard Medical School · NIH-11596403 · Data updated 2026-11-12
A study comparing how different high-income countries decide to approve, use, or stop using advanced heart techniques and how this affects patient outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | February 21, 2024 |
| Project end | January 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $55,679 |
| NIH project number | 3R01HL167887-03S7 |
| Project ID | NIH-11596403 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cardiovascular diseases in high-income countries where HTA decisions influence treatment availability.
✕Less likely to help
Patients in settings without major HTA influence or where data do not translate into practice changes.
What this research studies
This project builds on international data to see why some cardiovascular procedures are adopted quickly in some countries and de-adopted or used more slowly in others. It will examine health technology assessment processes and how these decisions influence real-world practice and outcomes for patients with cardiovascular conditions. The goal is to understand which policies lead to better value care and help patients across diverse settings benefit from effective treatments.
Why it matters
Potential benefit: Could help patients receive faster access to proven cardiovascular treatments and reduce wasteful or outdated practices.
How similar studies have gone: Prior work with IHSRC has laid groundwork for international comparisons, with ongoing insights into practice patterns across countries.
Where this research is happening
-
Harvard Medical School
Boston, United States Active
Researchers
- Principal investigator: Landon, Bruce E. — Harvard Medical School
- Study coordinator: Landon, Bruce E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.